TalkMed Shareholders Approve Privatization by Tamarind Health

TigerNews SG

07-16

TalkMed shareholders on Tuesday (Jul 15) overwhelmingly approved a privatization offer from Tamarind Health, with 98 shareholders (89.1% of those present) voting in favor. The resolution, backed by holders of 1.2 billion shares (99.9% of votes cast), paves the way for the company’s delisting at S$0.456 per share.

The deal, proposed by Tamarind-managed TW Troy on Dec 23, 2024, received regulatory clearance from Singapore’s Competition and Consumer Commission on Jun 27. Following shareholder approval, TalkMed will now seek court sanction for the scheme, with a hearing expected around Aug 5.

Trading of TalkMed shares is set to cease around Aug 8, with books closing on Aug 19. If court approval is granted and conditions met, the scheme will take effect on Aug 20, with payment to shareholders due by Aug 29 ahead of delisting by Sep 2.

The company also requested a lift of its trading halt on Tuesday evening. Its shares last traded at S$0.455.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1196067473"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1196067473\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/1196067473?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-16 14:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1196067473","market":"sg","top_or_hot":-1,"title":"TalkMed Shareholders Approve Privatization by Tamarind Health","media":"TigerNews SG","content":"<p>TalkMed shareholders on Tuesday (Jul 15) overwhelmingly approved a privatization offer from Tamarind Health, with 98 shareholders (89.1% of those present) voting in favor. The resolution, backed by holders of 1.2 billion shares (99.9% of votes cast), paves the way for the company’s delisting at S$0.456 per share.</p><p style=\"text-align: start;\">The deal, proposed by Tamarind-managed TW Troy on Dec 23, 2024, received regulatory clearance from Singapore’s Competition and Consumer Commission on Jun 27. Following shareholder approval, TalkMed will now seek court sanction for the scheme, with a hearing expected around Aug 5.</p><p style=\"text-align: start;\">Trading of TalkMed shares is set to cease around Aug 8, with books closing on Aug 19. If court approval is granted and conditions met, the scheme will take effect on Aug 20, with payment to shareholders due by Aug 29 ahead of delisting by Sep 2.</p><p style=\"text-align: start;\">The company also requested a lift of its trading halt on Tuesday evening. Its shares last traded at S$0.455.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TalkMed Shareholders Approve Privatization by Tamarind Health</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTalkMed Shareholders Approve Privatization by Tamarind Health\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1050470178\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/f17a9a7b68c877792d5e556261e9e709);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">TigerNews SG </p>\n<p class=\"h-time\">2025-07-16 14:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>TalkMed shareholders on Tuesday (Jul 15) overwhelmingly approved a privatization offer from Tamarind Health, with 98 shareholders (89.1% of those present) voting in favor. The resolution, backed by holders of 1.2 billion shares (99.9% of votes cast), paves the way for the company’s delisting at S$0.456 per share.</p><p style=\"text-align: start;\">The deal, proposed by Tamarind-managed TW Troy on Dec 23, 2024, received regulatory clearance from Singapore’s Competition and Consumer Commission on Jun 27. Following shareholder approval, TalkMed will now seek court sanction for the scheme, with a hearing expected around Aug 5.</p><p style=\"text-align: start;\">Trading of TalkMed shares is set to cease around Aug 8, with books closing on Aug 19. If court approval is granted and conditions met, the scheme will take effect on Aug 20, with payment to shareholders due by Aug 29 ahead of delisting by Sep 2.</p><p style=\"text-align: start;\">The company also requested a lift of its trading halt on Tuesday evening. Its shares last traded at S$0.455.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"5G3.SI","symbol_name":"TALKMED集团","start_time":0,"source_url":"","article_id":"1196067473","we_media_id":"1050470178","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1196067473","pubTimestamp":1752648299,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"TigerNews SG","introduction":"Providing stock market headlines, business news, financials and earnings","home_visible":1,"id":"1050470178","head_image":"https://community-static.tradeup.com/news/f17a9a7b68c877792d5e556261e9e709"},"summary":"TalkMed shareholders on Tuesday (Jul 15) overwhelmingly approved a privatization offer from Tamarind Health, with 98 shareholders (89.1% of those present) voting in favor. The resolution, backed by...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"5G3.SI":"TALKMED集团"},"translate_title":"TalkMed股东批准Tamarind Health私有化","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"5G3.SI":1.1},"content_text":"TalkMed shareholders on Tuesday (Jul 15) overwhelmingly approved a privatization offer from Tamarind Health, with 98 shareholders (89.1% of those present) voting in favor. The resolution, backed by holders of 1.2 billion shares (99.9% of votes cast), paves the way for the company’s delisting at S$0.456 per share.The deal, proposed by Tamarind-managed TW Troy on Dec 23, 2024, received regulatory clearance from Singapore’s Competition and Consumer Commission on Jun 27. Following shareholder approval, TalkMed will now seek court sanction for the scheme, with a hearing expected around Aug 5.Trading of TalkMed shares is set to cease around Aug 8, with books closing on Aug 19. If court approval is granted and conditions met, the scheme will take effect on Aug 20, with payment to shareholders due by Aug 29 ahead of delisting by Sep 2.The company also requested a lift of its trading halt on Tuesday evening. Its shares last traded at S$0.455.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}